Sartorius Stedim Biotech S.A. (SDMHF)
USD 201.5
(0.0%)
USD 201.5
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 882.4 Million EUR | -13.9% |
| 2022 | 1.02 Billion EUR | 30.89% |
| 2021 | 782.95 Million EUR | 65.77% |
| 2020 | 472.3 Million EUR | 43.92% |
| 2019 | 328.16 Million EUR | 30.22% |
| 2018 | 252 Million EUR | 35.77% |
| 2017 | 185.6 Million EUR | 8.5% |
| 2016 | 171.05 Million EUR | 16.39% |
| 2015 | 146.97 Million EUR | 33.64% |
| 2014 | 109.97 Million EUR | 19.31% |
| 2013 | 92.17 Million EUR | 8.34% |
| 2012 | 85.07 Million EUR | 28.07% |
| 2011 | 66.43 Million EUR | 30.83% |
| 2010 | 50.77 Million EUR | 8.69% |
| 2009 | 46.71 Million EUR | -23.31% |
| 2008 | 60.91 Million EUR | 13.33% |
| 2007 | 53.75 Million EUR | -24.01% |
| 2006 | 70.73 Million EUR | 1.59% |
| 2005 | 69.62 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 745.7 Million EUR | -6.45% |
| 2024 Q1 | 872.7 Million EUR | -1.1% |
| 2024 Q2 | 797.1 Million EUR | -8.66% |
| 2023 Q1 | 1.06 Billion EUR | 3.52% |
| 2023 Q2 | 1.03 Billion EUR | -2.62% |
| 2023 Q3 | 992 Million EUR | -3.98% |
| 2023 Q4 | 882.4 Million EUR | -11.05% |
| 2023 FY | 882.4 Million EUR | -13.9% |
| 2022 Q1 | 857.5 Million EUR | 9.52% |
| 2022 FY | 1.02 Billion EUR | 30.89% |
| 2022 Q2 | 964.1 Million EUR | 12.43% |
| 2022 Q3 | 1.05 Billion EUR | 9.8% |
| 2022 Q4 | 1.02 Billion EUR | -3.19% |
| 2021 Q3 | 703.9 Million EUR | 17.39% |
| 2021 Q4 | 782.95 Million EUR | 11.23% |
| 2021 FY | 782.95 Million EUR | 65.77% |
| 2021 Q1 | 534.8 Million EUR | 13.23% |
| 2021 Q2 | 599.6 Million EUR | 12.12% |
| 2020 Q2 | 407.9 Million EUR | 19.79% |
| 2020 Q1 | 340.5 Million EUR | 3.76% |
| 2020 FY | 472.3 Million EUR | 43.92% |
| 2020 Q4 | 472.3 Million EUR | 7.96% |
| 2020 Q3 | 437.5 Million EUR | 7.26% |
| 2019 Q4 | 328.16 Million EUR | 4.38% |
| 2019 FY | 328.16 Million EUR | 30.22% |
| 2019 Q2 | 285.9 Million EUR | 5.93% |
| 2019 Q3 | 314.4 Million EUR | 9.97% |
| 2019 Q1 | 269.9 Million EUR | 7.1% |
| 2018 Q3 | 240 Million EUR | 11.27% |
| 2018 Q1 | 203 Million EUR | 9.37% |
| 2018 Q4 | 252 Million EUR | 5.0% |
| 2018 FY | 252 Million EUR | 35.77% |
| 2018 Q2 | 215.7 Million EUR | 6.26% |
| 2017 Q4 | 185.6 Million EUR | 0.87% |
| 2017 FY | 185.6 Million EUR | 8.5% |
| 2017 Q1 | 180.8 Million EUR | 5.7% |
| 2017 Q2 | 179.8 Million EUR | -0.55% |
| 2017 Q3 | 184 Million EUR | 2.34% |
| 2016 FY | 171.05 Million EUR | 16.39% |
| 2016 Q3 | 175 Million EUR | 2.76% |
| 2016 Q2 | 170.3 Million EUR | 6.11% |
| 2016 Q1 | 160.5 Million EUR | 9.21% |
| 2016 Q4 | 171.05 Million EUR | -2.25% |
| 2015 Q4 | 146.97 Million EUR | 6.27% |
| 2015 Q3 | 138.3 Million EUR | 0.44% |
| 2015 Q2 | 137.7 Million EUR | 8.43% |
| 2015 Q1 | 127 Million EUR | 15.48% |
| 2015 FY | 146.97 Million EUR | 33.64% |
| 2014 FY | 109.97 Million EUR | 19.31% |
| 2014 Q4 | 109.97 Million EUR | -6.24% |
| 2014 Q3 | 117.3 Million EUR | 10.76% |
| 2014 Q2 | 105.9 Million EUR | 6.54% |
| 2014 Q1 | 99.4 Million EUR | 4.7% |
| 2013 FY | 92.17 Million EUR | 8.34% |
| 2013 Q4 | 94.93 Million EUR | 0.25% |
| 2013 Q2 | 89.7 Million EUR | 0.0% |
| 2013 Q3 | 94.7 Million EUR | 5.57% |
| 2012 FY | 85.07 Million EUR | 28.07% |
| 2012 Q2 | 78 Million EUR | 0.0% |
| 2011 Q2 | 62.5 Million EUR | 0.0% |
| 2011 FY | 66.43 Million EUR | 30.83% |
| 2010 Q2 | 56.6 Million EUR | 0.0% |
| 2010 FY | 50.77 Million EUR | 8.69% |
| 2009 FY | 46.71 Million EUR | -23.31% |
| 2009 Q4 | 46.71 Million EUR | 0.0% |
| 2008 FY | 60.91 Million EUR | 13.33% |
| 2007 FY | 53.75 Million EUR | -24.01% |
| 2006 FY | 70.73 Million EUR | 1.59% |
| 2005 FY | 69.62 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -659248.871% |
| Ansell Limited | 457.04 Million USD | -93.067% |
| Ansell Limited | 457.9 Million USD | -92.706% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | -1936.2% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -3163758.014% |
| Psykey, Inc. | 49.94 Thousand USD | -1766820.304% |
| ConvaTec Group Plc | 395.54 Million USD | -123.087% |
| ConvaTec Group Plc | 396.1 Million USD | -122.772% |
| Encision Inc. | 1.4 Million USD | -62823.489% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 9494397.396% |
| LifePoint, Inc. | 2.3 Million USD | -38110.002% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | -36620.766% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | -199990.703% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -960262.204% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | -90654.536% |
| SmileDirectClub, Inc. | 49.87 Million USD | -1669.259% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | -150.861% |
| SheerVision, Inc. | 339.66 Thousand USD | -259686.906% |
| United Health Products, Inc. | 33.59 Thousand USD | -2626246.806% |
| Vasamed, Inc. | 449.02 Thousand USD | -196413.358% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -10314336.002% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -273790.115% |